Veru Inc.

https://ir.verupharma.com/news-events/press-releases/detail/253/veru-to-report-fiscal-2026-second-quarter-financial-results

Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th MIAMI, FL, May 06, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…...

https://ir.verupharma.com/news-events/press-releases/detail/248/veru-reports-fiscal-year-2025-financial-results-and

Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress -- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in…...

https://ir.verupharma.com/news-events/press-releases/detail/247/veru-to-report-fiscal-year-2025-financial-results-on

Veru to Report Fiscal Year 2025 Financial Results on December 17th MIAMI, FL, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…...